Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020
The global virus filtration market is projected to reach USD 3.25 billion by 2020 from USD 1.82 billion in 2015, at a CAGR of 12.3% between 2015 and 2020. By product, the market includes kits and reagents, filtration systems, other products and services. Based on application segment includes biologicals, medical devices, water purification, and air purification. The biologicals segment is further classified into, vaccines and therapeutics, blood and blood products, cellular and gene therapy products, tissue and tissue products and stem cell products.
The end user segments included in this report are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies. The pharmaceutical & biotechnology companies segment is expected to hold the largest share of the virus filtration market in 2015.
The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global the virus filtration market in 2015. Asia is expected to register the fastest growth during the forecast period.
The growth of this market is mainly driven by the rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. In addition, increasing adoption of single-use technologies is the latest trend observed in the virus filtration market.
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global virus filtration market and its sub-segments. All percentage shares, splits, and breakdowns for market segments were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been considered, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub segment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all sub segments. It maps market sizes and growth rates for each sub segment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders such as
Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following:
The end user segments included in this report are pharmaceutical & biotechnology companies, contract research organizations, academic research institutes and medical devices companies. The pharmaceutical & biotechnology companies segment is expected to hold the largest share of the virus filtration market in 2015.
The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW). North America is expected to account for the largest share in the global the virus filtration market in 2015. Asia is expected to register the fastest growth during the forecast period.
The growth of this market is mainly driven by the rise in R&D expenditure, growth of biopharmaceutical industry, and increasing government support for pharmaceutical and biotechnology industry are driving factors of the virus filtration market. In addition, increasing adoption of single-use technologies is the latest trend observed in the virus filtration market.
A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global virus filtration market and its sub-segments. All percentage shares, splits, and breakdowns for market segments were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been considered, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each sub segment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all sub segments. It maps market sizes and growth rates for each sub segment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders such as
Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), and Pall Corporation (U.S.), Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Sartorius AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan) and WuXi PharmaTech (Cayman) Inc. (China).
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following:
- Product Development/Innovation: Product portfolios of the top players in the virus filtration market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
- Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the virus filtration market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various virus filtration across geographies
- Market Diversification: Exhaustive information about new products, recent developments, and investments in the virus filtration market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 MARKET SHARE ESTIMATION
2.3.1 KEY DATA FROM SECONDARY SOURCES
2.3.2 KEY DATA FROM PRIMARY SOURCES
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VIRUS FILTRATION MARKET OVERVIEW
4.2 LIFE CYCLE ANALYSIS, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 BY PRODUCT
5.1.2 BY APPLICATION
5.1.3 BY END USER
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing R&D spending
5.2.1.2 Growth in biopharmaceutical industry
5.2.1.3 Increasing government support for the pharmaceutical & biotechnology industry
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations for validation of filtration products
5.2.2.2 Highly consolidated market
5.2.3 OPPORTUNITIES
5.2.3.1 Asia presents high-growth opportunities
5.2.3.2 Increasing pharmaceutical outsourcing
5.2.4 TREND
5.2.4.1 Rising adoption of single-use technologies
6 VIRUS FILTRATION MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 KITS AND REAGENTS
6.3 FILTRATION SYSTEMS
6.4 SERVICES
6.5 OTHER PRODUCTS
7 VIRUS FILTRATION MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 BIOLOGICALS
7.2.1 VACCINES AND THERAPEUTICS
7.2.2 BLOOD AND BLOOD PRODUCTS
7.2.3 CELLULAR AND GENE THERAPY PRODUCTS
7.2.4 TISSUE AND TISSUE PRODUCTS
7.2.5 STEM CELL PRODUCTS
7.3 MEDICAL DEVICES
7.4 WATER PURIFICATION
7.5 AIR PURIFICATION
8 VIRUS FILTRATION MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3 CONTRACT RESEARCH ORGANIZATIONS
8.4 ACADEMIC RESEARCH INSTITUTES
8.5 MEDICAL DEVICE COMPANIES
9 VIRUS FILTRATION MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.4 ASIA
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 REST OF ASIA (ROA)
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIC OVERVIEW
10.3 MARKET SHARE ANALYSIS
10.4 COMPETITIVE SITUATION AND TRENDS
10.4.1 NEW PRODUCT LAUNCHES AND UPGRADES
10.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
10.4.3 MERGERS & ACQUISITIONS
10.4.4 EXPANSIONS
11 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION
11.2 MERCK KGAA
11.3 GENERAL ELECTRIC COMPANY
11.4 THERMO FISHER SCIENTIFIC, INC.
11.5 LONZA GROUP LTD.
11.6 PALL CORPORATION
11.7 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
11.8 SIGMA-ALDRICH CORPORATION
11.9 SARTORIUS AG
11.10 ASAHI KASEI MEDICAL CO., LTD.
11.11 WUXI PHARMATECH (CAYMAN) INC.
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 OTHER DEVELOPMENTS
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.6 AVAILABLE CUSTOMIZATIONS
12.7 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 MARKET SHARE ESTIMATION
2.3.1 KEY DATA FROM SECONDARY SOURCES
2.3.2 KEY DATA FROM PRIMARY SOURCES
2.4 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VIRUS FILTRATION MARKET OVERVIEW
4.2 LIFE CYCLE ANALYSIS, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.1.1 BY PRODUCT
5.1.2 BY APPLICATION
5.1.3 BY END USER
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing R&D spending
5.2.1.2 Growth in biopharmaceutical industry
5.2.1.3 Increasing government support for the pharmaceutical & biotechnology industry
5.2.2 RESTRAINTS
5.2.2.1 Stringent regulations for validation of filtration products
5.2.2.2 Highly consolidated market
5.2.3 OPPORTUNITIES
5.2.3.1 Asia presents high-growth opportunities
5.2.3.2 Increasing pharmaceutical outsourcing
5.2.4 TREND
5.2.4.1 Rising adoption of single-use technologies
6 VIRUS FILTRATION MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 KITS AND REAGENTS
6.3 FILTRATION SYSTEMS
6.4 SERVICES
6.5 OTHER PRODUCTS
7 VIRUS FILTRATION MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 BIOLOGICALS
7.2.1 VACCINES AND THERAPEUTICS
7.2.2 BLOOD AND BLOOD PRODUCTS
7.2.3 CELLULAR AND GENE THERAPY PRODUCTS
7.2.4 TISSUE AND TISSUE PRODUCTS
7.2.5 STEM CELL PRODUCTS
7.3 MEDICAL DEVICES
7.4 WATER PURIFICATION
7.5 AIR PURIFICATION
8 VIRUS FILTRATION MARKET, BY END USER
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.3 CONTRACT RESEARCH ORGANIZATIONS
8.4 ACADEMIC RESEARCH INSTITUTES
8.5 MEDICAL DEVICE COMPANIES
9 VIRUS FILTRATION MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.4 ASIA
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 REST OF ASIA (ROA)
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIC OVERVIEW
10.3 MARKET SHARE ANALYSIS
10.4 COMPETITIVE SITUATION AND TRENDS
10.4.1 NEW PRODUCT LAUNCHES AND UPGRADES
10.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
10.4.3 MERGERS & ACQUISITIONS
10.4.4 EXPANSIONS
11 COMPANY PROFILES
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION
11.2 MERCK KGAA
11.3 GENERAL ELECTRIC COMPANY
11.4 THERMO FISHER SCIENTIFIC, INC.
11.5 LONZA GROUP LTD.
11.6 PALL CORPORATION
11.7 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
11.8 SIGMA-ALDRICH CORPORATION
11.9 SARTORIUS AG
11.10 ASAHI KASEI MEDICAL CO., LTD.
11.11 WUXI PHARMATECH (CAYMAN) INC.
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 OTHER DEVELOPMENTS
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.6 AVAILABLE CUSTOMIZATIONS
12.7 RELATED REPORTS
LIST OF TABLES
Table 1 VIRUS FILTRATION MARKET SUMMARY
Table 2 INCREASING R&D SPENDING: THE PRIMARY GROWTH DRIVER FOR THE VIRUS FILTRATION MARKET
Table 3 STRINGENT REGULATORY POLICIES FOR VALIDATION OF FILTRATION PRODUCTS TO RESTRICT MARKET GROWTH
Table 4 ASIA PRESENTS HIGH-GROWTH OPPORTUNITIES IN THE VIRUS FILTRATION MARKET
Table 5 SINGLE-USE TECHNOLOGIES IS A MAJOR TREND OBSERVED IN THE VIRUS FILTRATION MARKET
Table 6 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 7 VIRUS FILTRATION KITS AND REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 8 VIRUS FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 9 VIRUS FILTRATION SERVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 10 OTHER VIRUS FILTRATION PRODUCTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 11 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 12 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 13 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY REGION, 2013–2020 (USD MILLION)
Table 14 VIRUS FILTRATION MARKET SIZE FOR VACCINES AND THERAPEUTICS, BY REGION, 2013–2020 (USD MILLION)
Table 15 VIRUS FILTRATION MARKET SIZE FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 16 VIRUS FILTRATION MARKET SIZE FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 17 VIRUS FILTRATION MARKET SIZE FOR TISSUE AND TISSUE PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 18 VIRUS FILTRATION MARKET SIZE FOR STEM CELL PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 19 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013–2020 (USD MILLION)
Table 20 VIRUS FILTRATION MARKET SIZE FOR WATER PURIFICATION APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 21 VIRUS FILTRATION MARKET SIZE FOR AIR PURIFICATION APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 22 VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 23 VIRUS FILTRATION MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013–2020 (USD MILLION)
Table 24 VIRUS FILTRATION MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 25 VIRUS FILTRATION MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013–2020 (USD MILLION)
Table 26 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2013–2020 (USD MILLION)
Table 27 VIRUS FILTRATION MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 28 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 29 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 30 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 31 NORTH AMERICA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 32 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 33 U.S.: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 34 U.S.: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 35 U.S.: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 36 U.S.: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 37 CANADA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 38 CANADA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 39 CANADA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 40 CANADA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 41 EUROPE: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 42 EUROPE: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 43 EUROPE: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 44 EUROPE: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 45 ASIA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 46 ASIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 47 ASIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 48 ASIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 49 ASIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 50 CHINA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 51 CHINA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 52 CHINA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 53 CHINA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 54 JAPAN: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 55 JAPAN: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 56 JAPAN: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 57 JAPAN: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 58 INDIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 59 INDIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 60 INDIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 61 INDIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 62 ROA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 63 ROA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 64 ROA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 65 ROA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 66 ROW: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 67 ROW: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 68 ROW: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 69 ROW: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 70 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND MARCH 2016
Table 71 NEW PRODUCT LAUNCHES AND UPGRADES, 2013–2016
Table 72 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013–2016
Table 73 MERGERS & ACQUISITIONS, 2013–2016
Table 74 EXPANSIONS, 2013–2016
Table 1 VIRUS FILTRATION MARKET SUMMARY
Table 2 INCREASING R&D SPENDING: THE PRIMARY GROWTH DRIVER FOR THE VIRUS FILTRATION MARKET
Table 3 STRINGENT REGULATORY POLICIES FOR VALIDATION OF FILTRATION PRODUCTS TO RESTRICT MARKET GROWTH
Table 4 ASIA PRESENTS HIGH-GROWTH OPPORTUNITIES IN THE VIRUS FILTRATION MARKET
Table 5 SINGLE-USE TECHNOLOGIES IS A MAJOR TREND OBSERVED IN THE VIRUS FILTRATION MARKET
Table 6 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 7 VIRUS FILTRATION KITS AND REAGENTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 8 VIRUS FILTRATION SYSTEMS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 9 VIRUS FILTRATION SERVICES MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 10 OTHER VIRUS FILTRATION PRODUCTS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 11 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 12 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 13 VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY REGION, 2013–2020 (USD MILLION)
Table 14 VIRUS FILTRATION MARKET SIZE FOR VACCINES AND THERAPEUTICS, BY REGION, 2013–2020 (USD MILLION)
Table 15 VIRUS FILTRATION MARKET SIZE FOR BLOOD AND BLOOD PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 16 VIRUS FILTRATION MARKET SIZE FOR CELLULAR AND GENE THERAPY PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 17 VIRUS FILTRATION MARKET SIZE FOR TISSUE AND TISSUE PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 18 VIRUS FILTRATION MARKET SIZE FOR STEM CELL PRODUCTS, BY REGION, 2013–2020 (USD MILLION)
Table 19 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICES, BY REGION, 2013–2020 (USD MILLION)
Table 20 VIRUS FILTRATION MARKET SIZE FOR WATER PURIFICATION APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 21 VIRUS FILTRATION MARKET SIZE FOR AIR PURIFICATION APPLICATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 22 VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 23 VIRUS FILTRATION MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2013–2020 (USD MILLION)
Table 24 VIRUS FILTRATION MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013–2020 (USD MILLION)
Table 25 VIRUS FILTRATION MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2013–2020 (USD MILLION)
Table 26 VIRUS FILTRATION MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2013–2020 (USD MILLION)
Table 27 VIRUS FILTRATION MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 28 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 29 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 30 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 31 NORTH AMERICA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 32 NORTH AMERICA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 33 U.S.: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 34 U.S.: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 35 U.S.: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 36 U.S.: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 37 CANADA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 38 CANADA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 39 CANADA: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 40 CANADA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 41 EUROPE: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 42 EUROPE: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 43 EUROPE: VIRUS FILTRATION BIOLOGICALS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 44 EUROPE: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 45 ASIA: VIRUS FILTRATION MARKET SIZE, BY COUNTRY, 2013–2020 (USD MILLION)
Table 46 ASIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 47 ASIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 48 ASIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 49 ASIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 50 CHINA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 51 CHINA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 52 CHINA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 53 CHINA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 54 JAPAN: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 55 JAPAN: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 56 JAPAN: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 57 JAPAN: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 58 INDIA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 59 INDIA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 60 INDIA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 61 INDIA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 62 ROA: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 63 ROA: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 64 ROA: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 65 ROA: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 66 ROW: VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2013–2020 (USD MILLION)
Table 67 ROW: VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 68 ROW: VIRUS FILTRATION MARKET SIZE FOR BIOLOGICALS, BY TYPE, 2013–2020 (USD MILLION)
Table 69 ROW: VIRUS FILTRATION MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 70 MARKET DEVELOPMENTS BETWEEN JANUARY 2013 AND MARCH 2016
Table 71 NEW PRODUCT LAUNCHES AND UPGRADES, 2013–2016
Table 72 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013–2016
Table 73 MERGERS & ACQUISITIONS, 2013–2016
Table 74 EXPANSIONS, 2013–2016
LIST OF FIGURES
Figure 1 GLOBAL VIRUS FILTRATION MARKET
Figure 2 RESEARCH DESIGN
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
Figure 8 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
Figure 9 BIOLOGICALS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
Figure 10 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
Figure 11 VIRUS FILTRATION MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
Figure 12 GLOBAL VIRUS FILTRATION MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
Figure 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE VIRUS FILTRATION MARKET IN 2015
Figure 14 ASIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 15 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
Figure 16 VIRUS FILTRATION MARKET SEGMENTATION: BY PRODUCT
Figure 17 VIRUS FILTRATION MARKET SEGMENTATION: BY APPLICATION
Figure 18 VIRUS FILTRATION MARKET SEGMENTATION: BY END USER
Figure 19 INCREASING R&D SPENDING WILL DRIVE THE VIRUS FILTRATION MARKET DURING THE FORECAST PERIOD
Figure 20 GLOBAL PHARMACEUTICAL R&D SPENDING (2001–2011)
Figure 21 VIRUS FILTRATION MARKET SEGMENTATION, BY PRODUCT
Figure 22 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN 2015
Figure 23 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION KITS AND REAGENTS MARKET IN 2015
Figure 24 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION SYSTEMS MARKET IN 2015
Figure 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF VIRUS FILTRATION SERVICES MARKET IN 2015
Figure 26 NORTH AMERICA TO DOMINATE THE OTHER VIRUS FILTRATION PRODUCTS MARKET IN 2015
Figure 27 VIRUS FILTRATION MARKET SEGMENTATION, BY APPLICATION
Figure 28 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN 2015
Figure 29 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
Figure 30 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
Figure 31 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR VACCINES AND THERAPEUTICS IN 2015
Figure 32 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR BLOOD AND BLOOD PRODUCTS IN 2015
Figure 33 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CELLULAR AND GENE THERAPY PRODUCTS IN 2015
Figure 34 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR TISSUE AND TISSUE PRODUCTS IN 2015
Figure 35 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR STEM CELL PRODUCTS IN 2015
Figure 36 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICES IN 2015
Figure 37 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR WATER PURIFICATION APPLICATIONS IN 2015
Figure 38 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR AIR PURIFICATION APPLICATIONS IN 2015
Figure 39 VIRUS FILTRATION MARKET SEGMENTATION, BY END USER
Figure 40 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 (USD MILLION)
Figure 41 PATENTS FILED: GLOBAL DISTRIBUTION IN 2012
Figure 42 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN 2015
Figure 43 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020
Figure 44 ASIA TO WITNESS HIGHEST GROWTH IN THE VIRUS FILTRATION MARKET FOR ACADEMIC RESEARCH INSTITUTES
Figure 45 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICE COMPANIES BETWEEN 2015 AND 2020
Figure 46 VIRUS FILTRATION MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020
Figure 47 VIRUS FILTRATION MARKET IN ASIA TO GROW AT THE HIGHEST RATE (2015 TO 2020)
Figure 48 NORTH AMERICA: VIRUS FILTRATION MARKET SNAPSHOT
Figure 49 U.S. TO DOMINATE THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
Figure 50 KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
Figure 51 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
Figure 52 VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE NORTH AMERICAN BIOLOGICALS MARKET IN 2015
Figure 53 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN NORTH AMERICA
Figure 54 KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE U.S. VIRUS FILTRATION MARKET IN 2015
Figure 55 BIOLOGICALS APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. VIRUS FILTRATION MARKET IN 2015
Figure 56 VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE U.S. VIRUS FILTRATION BIOLOGICALS MARKET IN 2015
Figure 57 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN THE U.S.
Figure 58 KITS & REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN CANADA IN 2015
Figure 59 BIOLOGICALS TO ACCOUNT FOR THE LARGEST OF THE VIRUS FILTRATION APPLICATIONS MARKET IN CANADA IN 2015
Figure 60 KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT OF VIRUS FILTRATION BIOLOGICALS MARKET IN CANADA
Figure 61 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CANADA
Figure 62 KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN VIRUS FILTRATION MARKET IN 2015
Figure 63 BIOLOGICALS TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATIONS MARKET IN EUROPE IN 2015
Figure 64 VACCINES AND THERAPEUTICS TO FORM THE LARGEST SEGMENT IN THE VIRUS FILTRATION BIOLOGICALS MARKET IN EUROPE
Figure 65 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN EUROPE
Figure 66 ASIAN VIRUS FILTRATION MARKET SNAPSHOT
Figure 67 CHINA ESTIMATED TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET IN 2015
Figure 68 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE ASIAN MARKET IN 2015
Figure 69 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATION MARKET IN ASIA IN 2015
Figure 70 VACCINES AND THERAPEUTICS TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
Figure 71 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN ASIA
Figure 72 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN CHINA IN 2015
Figure 73 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN CHINA IN 2015
Figure 74 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN CHINA IN 2015
Figure 75 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CHINA
Figure 76 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN JAPAN IN 2015
Figure 77 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN JAPAN IN 2015
Figure 78 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN JAPAN IN 2015
Figure 79 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN JAPAN
Figure 80 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN INDIA IN 2015
Figure 81 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN INDIA IN 2015
Figure 82 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN INDIA IN 2015
Figure 83 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN INDIA
Figure 84 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN ROA IN 2015
Figure 85 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN ROA IN 2015
Figure 86 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROA IN 2015
Figure 87 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN ROA
Figure 88 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW VIRUS FILTRATION MARKET IN 2015
Figure 89 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION APPLICATION MARKET IN 2015
Figure 90 VACCINES AND THERAPEUTICS ESTIMATED TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROW IN 2015
Figure 91 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION END-USER MARKET
Figure 92 NEW PRODUCT LAUNCHES AND UPGRADES WAS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE VIRUS FILTRATION MARKET
Figure 93 VIRUS FILTRATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
Figure 94 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
Figure 95 COMPANY SNAPSHOT: MERCK & CO., INC.
Figure 96 COMPANY SNAPSHOT: GENERAL ELECTRIC COMPANY
Figure 97 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
Figure 98 COMPANY SNAPSHOT: LONZA GROUP LTD.
Figure 99 COMPANY SNAPSHOT: PALL CORPORATION
Figure 100 COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Figure 101 COMPANY SNAPSHOT: SIGMA-ALDRICH CORPORATION
Figure 102 COMPANY SNAPSHOT: SARTORIUS AG
Figure 103 COMPANY SNAPSHOT: ASAHI KASEI MEDICAL CO., LTD.
Figure 104 COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC.
Figure 1 GLOBAL VIRUS FILTRATION MARKET
Figure 2 RESEARCH DESIGN
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 VIRUS FILTRATION MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
Figure 8 VIRUS FILTRATION MARKET SIZE, BY APPLICATION, 2015 VS. 2020 (USD MILLION)
Figure 9 BIOLOGICALS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION)
Figure 10 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
Figure 11 VIRUS FILTRATION MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
Figure 12 GLOBAL VIRUS FILTRATION MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
Figure 13 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE THE VIRUS FILTRATION MARKET IN 2015
Figure 14 ASIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 15 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES
Figure 16 VIRUS FILTRATION MARKET SEGMENTATION: BY PRODUCT
Figure 17 VIRUS FILTRATION MARKET SEGMENTATION: BY APPLICATION
Figure 18 VIRUS FILTRATION MARKET SEGMENTATION: BY END USER
Figure 19 INCREASING R&D SPENDING WILL DRIVE THE VIRUS FILTRATION MARKET DURING THE FORECAST PERIOD
Figure 20 GLOBAL PHARMACEUTICAL R&D SPENDING (2001–2011)
Figure 21 VIRUS FILTRATION MARKET SEGMENTATION, BY PRODUCT
Figure 22 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN 2015
Figure 23 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION KITS AND REAGENTS MARKET IN 2015
Figure 24 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION SYSTEMS MARKET IN 2015
Figure 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF VIRUS FILTRATION SERVICES MARKET IN 2015
Figure 26 NORTH AMERICA TO DOMINATE THE OTHER VIRUS FILTRATION PRODUCTS MARKET IN 2015
Figure 27 VIRUS FILTRATION MARKET SEGMENTATION, BY APPLICATION
Figure 28 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN 2015
Figure 29 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
Figure 30 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
Figure 31 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR VACCINES AND THERAPEUTICS IN 2015
Figure 32 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR BLOOD AND BLOOD PRODUCTS IN 2015
Figure 33 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CELLULAR AND GENE THERAPY PRODUCTS IN 2015
Figure 34 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR TISSUE AND TISSUE PRODUCTS IN 2015
Figure 35 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR STEM CELL PRODUCTS IN 2015
Figure 36 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICES IN 2015
Figure 37 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION MARKET FOR WATER PURIFICATION APPLICATIONS IN 2015
Figure 38 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR AIR PURIFICATION APPLICATIONS IN 2015
Figure 39 VIRUS FILTRATION MARKET SEGMENTATION, BY END USER
Figure 40 VIRUS FILTRATION MARKET SIZE, BY END USER, 2015 (USD MILLION)
Figure 41 PATENTS FILED: GLOBAL DISTRIBUTION IN 2012
Figure 42 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN 2015
Figure 43 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS BETWEEN 2015 AND 2020
Figure 44 ASIA TO WITNESS HIGHEST GROWTH IN THE VIRUS FILTRATION MARKET FOR ACADEMIC RESEARCH INSTITUTES
Figure 45 NORTH AMERICA TO DOMINATE THE VIRUS FILTRATION MARKET FOR MEDICAL DEVICE COMPANIES BETWEEN 2015 AND 2020
Figure 46 VIRUS FILTRATION MARKET, BY REGION (MARKET SIZE AND GROWTH RATE), 2015-2020
Figure 47 VIRUS FILTRATION MARKET IN ASIA TO GROW AT THE HIGHEST RATE (2015 TO 2020)
Figure 48 NORTH AMERICA: VIRUS FILTRATION MARKET SNAPSHOT
Figure 49 U.S. TO DOMINATE THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
Figure 50 KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
Figure 51 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN VIRUS FILTRATION MARKET IN 2015
Figure 52 VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE NORTH AMERICAN BIOLOGICALS MARKET IN 2015
Figure 53 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN NORTH AMERICA
Figure 54 KITS & REAGENTS ESTIMATED TO FORM THE LARGEST PRODUCT SEGMENT IN THE U.S. VIRUS FILTRATION MARKET IN 2015
Figure 55 BIOLOGICALS APPLICATION SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. VIRUS FILTRATION MARKET IN 2015
Figure 56 VACCINES & THERAPEUTICS ESTIMATED TO FORM THE LARGEST SEGMENT IN THE U.S. VIRUS FILTRATION BIOLOGICALS MARKET IN 2015
Figure 57 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN THE U.S.
Figure 58 KITS & REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN CANADA IN 2015
Figure 59 BIOLOGICALS TO ACCOUNT FOR THE LARGEST OF THE VIRUS FILTRATION APPLICATIONS MARKET IN CANADA IN 2015
Figure 60 KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT OF VIRUS FILTRATION BIOLOGICALS MARKET IN CANADA
Figure 61 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CANADA
Figure 62 KITS & REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE EUROPEAN VIRUS FILTRATION MARKET IN 2015
Figure 63 BIOLOGICALS TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATIONS MARKET IN EUROPE IN 2015
Figure 64 VACCINES AND THERAPEUTICS TO FORM THE LARGEST SEGMENT IN THE VIRUS FILTRATION BIOLOGICALS MARKET IN EUROPE
Figure 65 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO COMMAND THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN EUROPE
Figure 66 ASIAN VIRUS FILTRATION MARKET SNAPSHOT
Figure 67 CHINA ESTIMATED TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET IN 2015
Figure 68 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE ASIAN MARKET IN 2015
Figure 69 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION APPLICATION MARKET IN ASIA IN 2015
Figure 70 VACCINES AND THERAPEUTICS TO DOMINATE THE ASIAN VIRUS FILTRATION MARKET FOR BIOLOGICALS IN 2015
Figure 71 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN ASIA
Figure 72 KITS AND REAGENTS TO FORM THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN CHINA IN 2015
Figure 73 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATIONS MARKET IN CHINA IN 2015
Figure 74 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN CHINA IN 2015
Figure 75 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN CHINA
Figure 76 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN JAPAN IN 2015
Figure 77 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN JAPAN IN 2015
Figure 78 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN JAPAN IN 2015
Figure 79 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN JAPAN
Figure 80 KITS AND REAGENTS TO DOMINATE THE VIRUS FILTRATION PRODUCTS MARKET IN INDIA IN 2015
Figure 81 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN INDIA IN 2015
Figure 82 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN INDIA IN 2015
Figure 83 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE VIRUS FILTRATION END-USER MARKET IN INDIA
Figure 84 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE VIRUS FILTRATION MARKET IN ROA IN 2015
Figure 85 BIOLOGICALS TO DOMINATE THE VIRUS FILTRATION APPLICATION MARKET IN ROA IN 2015
Figure 86 VACCINES AND THERAPEUTICS TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROA IN 2015
Figure 87 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE VIRUS FILTRATION END-USER MARKET IN ROA
Figure 88 KITS AND REAGENTS ESTIMATED TO BE THE LARGEST PRODUCT SEGMENT IN THE ROW VIRUS FILTRATION MARKET IN 2015
Figure 89 BIOLOGICALS TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION APPLICATION MARKET IN 2015
Figure 90 VACCINES AND THERAPEUTICS ESTIMATED TO DOMINATE THE VIRUS FILTRATION MARKET FOR BIOLOGICALS IN ROW IN 2015
Figure 91 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE ROW VIRUS FILTRATION END-USER MARKET
Figure 92 NEW PRODUCT LAUNCHES AND UPGRADES WAS THE KEY STRATEGY ADOPTED BY PLAYERS IN THE VIRUS FILTRATION MARKET
Figure 93 VIRUS FILTRATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
Figure 94 FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
Figure 95 COMPANY SNAPSHOT: MERCK & CO., INC.
Figure 96 COMPANY SNAPSHOT: GENERAL ELECTRIC COMPANY
Figure 97 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC.
Figure 98 COMPANY SNAPSHOT: LONZA GROUP LTD.
Figure 99 COMPANY SNAPSHOT: PALL CORPORATION
Figure 100 COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Figure 101 COMPANY SNAPSHOT: SIGMA-ALDRICH CORPORATION
Figure 102 COMPANY SNAPSHOT: SARTORIUS AG
Figure 103 COMPANY SNAPSHOT: ASAHI KASEI MEDICAL CO., LTD.
Figure 104 COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC.
